News
Global Pharma Packaging Market Set For Decade-Long Growth
Over the course of the next ten years, the global market for pharmaceutical grade plastic packaging is expected to see consistent growth.
Over the next ten years, the global market for pharmaceutical grade plastic packaging is likely to see tremendous...
News
EC approves Celltrion’s SteQeyma, a biosimilar to Stelara for the treatment of multiple chronic inflammatory diseases
The European Commission (EC) approval is based on the totality of evidence including the results from a Phase III study in adults with moderate to severe plaque psoriasis.
Celltrion today announced that the European Commission (EC) has approved the use...
News
Bisam Pharmaceuticals Unveils Quick Vitals: The World’s First AI and Deep Learning-Powered Health Monitoring App
Bisam Pharmaceuticals has launched “Quick Vitals,” the world’s first health monitoring application powered by AI and Deep Learning technologies. The launch event took place at Hotel Avasa in Hyderabad, marking a significant milestone in the intersection of technology and...
News
Moderna Receives EC Approval for RSV Vaccine mRESVIA
Moderna, Inc announced that the EC has granted marketing authorization for mRESVIA® (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The marketing...
News
VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences
VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based...
Drug Research
ST Pharm and Quantoom Partner to Enhance RNA Manufacturing Flexibility
ST Pharm and Quantoom Biosciences have announced an extended collaboration to advance the development and manufacturing of RNA-based vaccines and therapeutics. This partnership integrates the complementary strengths of both companies to enhance the global supply of critical RNA manufacturing...
Drug Research
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
Bridge Biotherapeutics, a clinical-stage biotech company, announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen’s DNA-encoded...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
